{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:04:08Z","timestamp":1789902248288,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20272"],"award-info":[{"award-number":["U22A20272"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304503"],"award-info":[{"award-number":["82304503"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574396"],"award-info":[{"award-number":["82574396"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2288101"],"award-info":[{"award-number":["T2288101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.phrs.2026.108406","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:25:06Z","timestamp":1787153106000},"page":"108406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Systematic screening identifies USP20 as an accelerator of metabolic dysfunction-associated steatotic liver disease via driving de novo lipogenesis"],"prefix":"10.1016","volume":"232","author":[{"given":"Xiaoxuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nengneng","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruru","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zequn","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suowen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phrs.2026.108406_bib1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.phrs.2026.108406_bib2","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","article-title":"Natural history and progression of metabolic dysfunction-associated steatotic liver disease","volume":"9","author":"Hagstr\u00f6m","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108406_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","article-title":"Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics","volume":"7","author":"Duan","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2026.108406_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"issue":"17","key":"10.1016\/j.phrs.2026.108406_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140989","article-title":"Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice","volume":"131","author":"Singh","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.phrs.2026.108406_bib6","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s42255-022-00627-4","article-title":"Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis","volume":"4","author":"Zhou","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.phrs.2026.108406_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","article-title":"The biochemistry and physiology of mitochondrial fatty acid \u03b2-oxidation and its genetic disorders","volume":"78","author":"Houten","year":"2016","journal-title":"Annu. Rev. Physiol."},{"issue":"8","key":"10.1016\/j.phrs.2026.108406_bib8","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.cmet.2021.05.006","article-title":"TMEM41B acts as an ER scramblase required for lipoprotein biogenesis and lipid homeostasis","volume":"33","author":"Huang","year":"2021","journal-title":"Cell. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2026.108406_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/gutjnl-2018-317581","article-title":"Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans","volume":"69","author":"Che","year":"2020","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.phrs.2026.108406_bib10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108406_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41392-023-01405-8","article-title":"FBXW7\u03b2 loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth","volume":"8","author":"Wei","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.phrs.2026.108406_bib12","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.7150\/ijbs.101039","article-title":"Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer","volume":"20","author":"Li","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phrs.2026.108406_bib13","doi-asserted-by":"crossref","unstructured":"Breast Cancer Brain Metastases Rely on FASN-Mediated Lipid Biosynthesis. Cancer Discov. 2021;11(6):1315.","DOI":"10.1158\/2159-8290.CD-RW2021-051"},{"issue":"5","key":"10.1016\/j.phrs.2026.108406_bib14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41419-022-04926-2","article-title":"FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis","volume":"13","author":"Du","year":"2022","journal-title":"Cell. Death Dis."},{"issue":"8","key":"10.1016\/j.phrs.2026.108406_bib15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrm2731","article-title":"Breaking the chains: structure and function of the deubiquitinases","volume":"10","author":"Komander","year":"2009","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"7838","key":"10.1016\/j.phrs.2026.108406_bib16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-020-2928-y","article-title":"Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis","volume":"588","author":"Lu","year":"2020","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.phrs.2026.108406_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100626","article-title":"siRNA nanoparticle targeting Usp20 lowers lipid levels and ameliorates metabolic syndrome in mice","volume":"65","author":"Ding","year":"2024","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.phrs.2026.108406_bib18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort(\u2606)","volume":"73","author":"Anstee","year":"2020","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108406_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd.2017.152","article-title":"Deubiquitylating enzymes and drug discovery: emerging opportunities","volume":"17","author":"Harrigan","year":"2018","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"1","key":"10.1016\/j.phrs.2026.108406_bib20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41419-025-07772-0","article-title":"Targeting USP18 overcomes acquired resistance in hepatocellular carcinoma by regulating NCOA4 deISGylation and ferroptosis","volume":"16","author":"Ye","year":"2025","journal-title":"Cell. Death Dis."},{"issue":"6","key":"10.1016\/j.phrs.2026.108406_bib21","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/hep.29375","article-title":"USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity","volume":"66","author":"An","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.phrs.2026.108406_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.114235","article-title":"Deubiquitinase USP18 inhibits hepatic stellate cells activation and alleviates liver fibrosis via regulation of TAK1 activity","volume":"442","author":"Zhang","year":"2024","journal-title":"Exp. Cell. Res."},{"issue":"11","key":"10.1016\/j.phrs.2026.108406_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay1109","article-title":"Protein modification with ISG15 blocks coxsackievirus pathology by antiviral and metabolic reprogramming","volume":"6","author":"Kespohl","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2026.108406_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41588-025-02237-8","article-title":"Single-cell eQTL analysis identifies genetic variation underlying metabolic dysfunction-associated steatohepatitis","author":"Hong","year":"2025","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2026.108406_bib25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease","volume":"59","author":"Ryan","year":"2013","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108406_bib26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"22","key":"10.1016\/j.phrs.2026.108406_bib27","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"Jama"},{"issue":"8","key":"10.1016\/j.phrs.2026.108406_bib28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108406_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads0535","article-title":"Ketogenesis supports hepatic polyunsaturated fatty acid homeostasis via fatty acid elongation","volume":"11","author":"Queathem","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.phrs.2026.108406_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-023-44364-y","article-title":"Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use","volume":"15","author":"Worthmann","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108406_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.06.030","article-title":"Brain endothelial gap junction coupling enables rapid vasodilation propagation during neurovascular coupling","author":"Krolak","year":"2025","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.phrs.2026.108406_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/nu16234151","article-title":"Novel choline-deficient and 0.1%-methionine-added high-fat diet induces burned-out metabolic-dysfunction-associated steatohepatitis with inflammation by rapid immune cell infiltration on male mice","volume":"16","author":"Sakaguchi","year":"2024","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.phrs.2026.108406_bib33","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41419-020-03075-8","article-title":"USP7 mediates pathological hepatic de novo lipogenesis through promoting stabilization and transcription of ZNF638","volume":"11","author":"Ni","year":"2020","journal-title":"Cell. Death Dis."},{"issue":"8","key":"10.1016\/j.phrs.2026.108406_bib34","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41419-023-06091-6","article-title":"USP14 governs CYP2E1 to promote nonalcoholic fatty liver disease through deubiquitination and stabilization of HSP90AA1","volume":"14","author":"Wei","year":"2023","journal-title":"Cell. Death Dis."},{"issue":"7","key":"10.1016\/j.phrs.2026.108406_bib35","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/s12276-023-01036-7","article-title":"Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"55","author":"Baek","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108406_bib36","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12929-025-01148-4","article-title":"USP24 upregulation stabilizes PKA-C\u03b1 to promote lipogenesis, inflammation, and fibrosis during MASH progression","volume":"32","author":"Ning","year":"2025","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2026.108406_bib37","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ymthe.2025.01.046","article-title":"The deubiquitinase USP28 maintains the expression of PPAR\u03b3 and its inactivation protects mice from diet-induced MASH and hepatocarcinoma","volume":"33","author":"Cai","year":"2025","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.phrs.2026.108406_bib38","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.cmet.2024.07.014","article-title":"Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11","volume":"36","author":"Zhou","year":"2024","journal-title":"Cell. Metab."},{"key":"10.1016\/j.phrs.2026.108406_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-026-10160-z","article-title":"RYK is a GPNMB receptor that drives MASH","author":"Xi","year":"2026","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2026.108406_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"9","key":"10.1016\/j.phrs.2026.108406_bib41","article-title":"Acetyl-CoA Carboxylase Inhibitors for Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"18","author":"Hasanatuludhhiyah","year":"2025","journal-title":"Pharm. (Basel)"},{"issue":"3","key":"10.1016\/j.phrs.2026.108406_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100339","article-title":"Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: prevention by fenofibrate","volume":"64","author":"Dandan","year":"2023","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2026.108406_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115586","article-title":"SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors","volume":"170","author":"Sun","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.phrs.2026.108406_bib44","article-title":"Emerging role of Fatty acid synthase in tumor initiation: implications for cancer prevention","volume":"7","author":"Bueno","year":"2020","journal-title":"Mol. Cell. Oncol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108406_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16071313","article-title":"Targeting dysregulated lipid metabolism in cancer with pharmacological inhibitors","volume":"16","author":"Gupta","year":"2024","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.phrs.2026.108406_bib46","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/fon.10.11","article-title":"Fatty acid synthase as a potential therapeutic target in cancer","volume":"6","author":"Flavin","year":"2010","journal-title":"Future Oncol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108406_bib47","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/hep.32359","article-title":"Therapeutic efficacy of FASN inhibition in preclinical models of HCC","volume":"76","author":"Wang","year":"2022","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.phrs.2026.108406_bib48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/1878-0261.13582","article-title":"Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology","volume":"18","author":"Menendez","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.phrs.2026.108406_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115352","article-title":"Ubiquitin-specific protease 20 in human disease: Emerging role and therapeutic implications","volume":"206","author":"Qin","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108406_bib50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.omto.2021.11.004","article-title":"USP18 and USP20 restrict oHSV-1 replication in resistant human oral squamous carcinoma cell line SCC9 and affect the viability of SCC9 cells","volume":"23","author":"Lu","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"issue":"6","key":"10.1016\/j.phrs.2026.108406_bib51","doi-asserted-by":"crossref","first-page":"901","DOI":"10.17305\/bjbms.2022.7206","article-title":"Mechanism of OTUD5 in non-small cell lung cancer cell proliferation, invasion, and migration","volume":"22","author":"Li","year":"2022","journal-title":"Bosn. J. Basic. Med. Sci."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182600321X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182600321X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:56:18Z","timestamp":1789901778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366182600321X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S104366182600321X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108406","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic screening identifies USP20 as an accelerator of metabolic dysfunction-associated steatotic liver disease via driving de novo lipogenesis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108406"}}